Literature DB >> 11420731

DNA methylation, methyltransferases, and cancer.

K D Robertson1.   

Abstract

The field of epigenetics has recently moved to the forefront of studies relating to diverse processes such as transcriptional regulation, chromatin structure, genome integrity, and tumorigenesis. Recent work has revealed how DNA methylation and chromatin structure are linked at the molecular level and how methylation anomalies play a direct causal role in tumorigenesis and genetic disease. Much new information has also come to light regarding the cellular methylation machinery, known as the DNA methyltransferases, in terms of their roles in mammalian development and the types of proteins they are known to interact with. This information has forced a new view for the role of DNA methyltransferases. Rather than enzymes that act in isolation to copy methylation patterns after replication, the types of interactions discovered thus far indicate that DNA methyltransferases may be components of larger complexes actively involved in transcriptional control and chromatin structure modulation. These new findings will likely enhance our understanding of the myriad roles of DNA methylation in disease as well as point the way to novel therapies to prevent or repair these defects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420731     DOI: 10.1038/sj.onc.1204341

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  226 in total

1.  Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation.

Authors:  J-I Lai; Y-C Lai; Y-C Chen; N-K Wang; J-N Pan; W-S Wang; S-C Chang
Journal:  Cancer Gene Ther       Date:  2017-08-04       Impact factor: 5.987

2.  Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins.

Authors:  Christopher D Carvin; Rebecca D Parr; Michael P Kladde
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

3.  Genes and transposons are differentially methylated in plants, but not in mammals.

Authors:  Pablo D Rabinowicz; Lance E Palmer; Bruce P May; Michael T Hemann; Scott W Lowe; W Richard McCombie; Robert A Martienssen
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

4.  The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.

Authors:  Chi-Neu Tsai; Chia-Lung Tsai; Ka-Po Tse; Hwan-You Chang; Yu-Sun Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

5.  Is caspase-8 a neuroendocrine lung tumor suppressor?

Authors:  Suparna Mazumder; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2002 Jan-Feb       Impact factor: 4.742

6.  Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.

Authors:  Celeste Holz-Schietinger; Doug M Matje; Norbert O Reich
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

7.  Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation?

Authors:  Ajay Goel
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

8.  Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jing-Jing Zhang; Yi Zhu; Yan Zhu; Jun-Li Wu; Wen-Biao Liang; Rong Zhu; Ze-Kuan Xu; Qing Du; Yi Miao
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

9.  Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells.

Authors:  Zan Zhang; Anhua Lei; Liyang Xu; Lu Chen; Yonglong Chen; Xuena Zhang; Yan Gao; Xiaoli Yang; Min Zhang; Ying Cao
Journal:  J Biol Chem       Date:  2017-06-20       Impact factor: 5.157

10.  Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Authors:  Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Journal:  J Mol Med (Berl)       Date:  2007-06-15       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.